Taken together, both the investigations suggested a protective role of XIST knockdown in LPS-induced inflammatory injury in WI-38 cells via sponging miRNAs, TLR4, and NF-κB pathways, thereby providing a novel target for the treatment of pneumonia. Here, NFKB1 is linked to pneumonia.